Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 10.39B | 10.76B | 9.86B | 9.16B | 8.12B | 7.90B |
Gross Profit | 4.26B | 4.50B | 3.93B | 3.59B | 2.92B | 2.86B |
EBITDA | 1.95B | 2.39B | 1.82B | 1.54B | 944.46M | 880.78M |
Net Income | 1.25B | 1.56B | 1.01B | 860.53M | 406.15M | 432.55M |
Balance Sheet | ||||||
Total Assets | 18.46B | 19.35B | 18.57B | 17.00B | 16.15B | 15.32B |
Cash, Cash Equivalents and Short-Term Investments | 3.77B | 4.82B | 4.38B | 4.41B | 4.83B | 4.68B |
Total Debt | 147.00M | 142.70M | 170.00M | 234.48M | 404.19M | 253.14M |
Total Liabilities | 2.35B | 2.56B | 2.75B | 2.40B | 2.30B | 1.80B |
Stockholders Equity | 16.09B | 16.77B | 15.81B | 14.59B | 13.84B | 13.52B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.16B | 287.35M | -80.29M | 634.15M | 925.57M |
Operating Cash Flow | 0.00 | 1.30B | 892.35M | 135.71M | 849.15M | 1.14B |
Investing Cash Flow | 0.00 | -325.40M | -449.61M | -91.69M | -359.52M | -285.64M |
Financing Cash Flow | 0.00 | -514.47M | -431.38M | -476.89M | -393.04M | -409.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥21.58B | 11.40 | 2.82% | 9.88% | 11.83% | ||
72 Outperform | ¥12.84B | 9.61 | 5.02% | 4.80% | 32.85% | ||
71 Outperform | ¥6.44B | 12.97 | 2.61% | 13.34% | -74.02% | ||
69 Neutral | ¥17.69B | 16.64 | 3.34% | 2.10% | 5.08% | ||
68 Neutral | ¥81.74B | 13.83 | 3.37% | 7.11% | 7.49% | ||
62 Neutral | ¥9.19B | 25.33 | 2.44% | 4.03% | -2.88% | ||
57 Neutral | HK$14.47B | 9.41 | -0.60% | 4.32% | 7.09% | -37.88% |